Learn More
Medchemexpress LLC 1-(2-oxo-2-(3'-(trifluoromethyl)-[1,1'-biphenyl]-4-yl)ethyl)-5-(pyrrolidin-1-ylsulfonyl)pyridin-2(1H)-one | 1996629-79-8 | 99.6% | 490.49 g/mol | C24H21F3N2O4S | 10MG

Supplier: Medchemexpress LLC HY12471110MG
TBOPP is a research-grade small-molecule inhibitor selective for DOCK1, intended for preclinical and biochemical studies. It inhibits DOCK1 with an IC50 of 8.4 μM and binds the DOCK1 DHR-2 domain with a Kd of 7.1 μM; TBOPP has reported anti-tumor activity in multiple tumor models. The compound is supplied as a white to off-white solid with high purity and is typically prepared in DMSO for solution-based assays.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.